Robert W. Hesslein

Insider Reports History

Entity
Individual
Location
C/O Foundation Medicine, Inc., One Kendall Square, Suite B3501, Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Robert W. Hesslein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert W. Hesslein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, CLO and Secretary Common Stock 7.25K $2.03M $280.00 Oct 1, 2024 Direct
Voyager Therapeutics, Inc. Senior VP & General Counsel Common Stock 102K $731K $7.15 Mar 20, 2023 Direct

Insider Reports Filed by Robert W. Hesslein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALNY ALNYLAM PHARMACEUTICALS, INC. Oct 1, 2024 1 $0 4 Oct 3, 2024 EVP, CLO and Secretary
ALNY ALNYLAM PHARMACEUTICALS, INC. Sep 30, 2024 0 $0 3 Oct 3, 2024 EVP, CLO and Secretary
VYGR Voyager Therapeutics, Inc. Mar 20, 2023 1 -$34.2K 4 Mar 22, 2023 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Feb 17, 2023 1 -$24.6K 4 Feb 22, 2023 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Feb 13, 2023 1 -$22K 4 Feb 15, 2023 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Jan 17, 2023 2 -$21.5K 4 Jan 19, 2023 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Apr 4, 2022 1 -$23K 4 Apr 6, 2022 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Mar 21, 2022 2 -$41.1K 4 Mar 23, 2022 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Feb 17, 2022 1 -$14.6K 4 Feb 22, 2022 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Feb 11, 2022 1 -$10.9K 4 Feb 15, 2022 Senior VP & General Counsel
VYGR Voyager Therapeutics, Inc. Jan 13, 2022 2 $0 4 Jan 18, 2022 Senior VP & General Counsel